Global Gene Expression Analysis Industry (2020 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 19, 2021--
The “Gene Expression Analysis - Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Gene Expression Analysis estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$6.1 Billion by 2027, growing at a CAGR of 7.5% over the analysis period 2020-2027.
Instruments, one of the segments analyzed in the report, is projected to record a 7.1% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $992.8 Million, While China is Forecast to Grow at 11.4% CAGR
The Gene Expression Analysis market in the U.S. is estimated at US$992.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 11.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 6.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
Services Segment to Record 7.3% CAGR
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$549.3 Million in the year 2020 will reach a projected size of US$867 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$841.1 Million by the year 2027, while Latin America will expand at a 8.7% CAGR through the analysis period.
- Agilent Technologies
- Bio-Rad Laboratories,Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche
- Ge Healthcare
- Novogene Corporation
- Oxford Gene Technology
- Pacific Biosciences of California, Inc.
- Perkinelmer, Inc.
- Qiagen N.V.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- UNITED STATES
- UNITED KINGDOM
- REST OF EUROPE
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- LATIN AMERICA
- REST OF LATIN AMERICA
- MIDDLE EAST
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- REST OF MIDDLE EAST
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/ifz85m
View source version on businesswire.com:https://www.businesswire.com/news/home/20210419005614/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 04/19/2021 10:42 AM/DISC: 04/19/2021 10:42 AM